Kaushal Asrani

566 total citations
17 papers, 408 citations indexed

About

Kaushal Asrani is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Kaushal Asrani has authored 17 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cell Biology. Recurrent topics in Kaushal Asrani's work include Tuberous Sclerosis Complex Research (4 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Kaushal Asrani is often cited by papers focused on Tuberous Sclerosis Complex Research (4 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Kaushal Asrani collaborates with scholars based in United States, South Korea and Japan. Kaushal Asrani's co-authors include Tamara L. Lotan, Jeffrey A. Winkles, Nhan L. Tran, Juhyung Woo, Thiago Vidotto, Hans B. Liu, Pedram Argani, Daniela C. Salles, Sharron A.N. Brown and Pornima Phatak and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kaushal Asrani

15 papers receiving 406 citations

Peers

Kaushal Asrani

PRM

ONCOL

PHYSI

Shahenda El‐Naggar Egypt

Leslie A. Caromile United States

Sayali Joseph United States

Xisong Liang China

Catharina Conrad Germany

Ilsa Coleman United States

Dao Doan United States

Anju Karki United States

Jingtong Zhai China

Shahenda El‐Naggar Egypt

Kaushal Asrani

337 ×1.5

60 ×0.5

PRM

113 ×1.0

225 ×2.0

ONCOL

34 ×0.6

PHYSI

Citations per year, relative to Kaushal Asrani Kaushal Asrani (= 1×) peers Shahenda El‐Naggar

Countries citing papers authored by Kaushal Asrani

Since Specialization

Citations

This map shows the geographic impact of Kaushal Asrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaushal Asrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaushal Asrani more than expected).

Fields of papers citing papers by Kaushal Asrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaushal Asrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaushal Asrani. The network helps show where Kaushal Asrani may publish in the future.

Co-authorship network of co-authors of Kaushal Asrani

This figure shows the co-authorship network connecting the top 25 collaborators of Kaushal Asrani. A scholar is included among the top collaborators of Kaushal Asrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaushal Asrani. Kaushal Asrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Huili, Ana Teresa Amaral, Thiago Vidotto, et al.. (2025). mTOR ‐mediated upregulation of B7 ‐ H3 in MiT / TFE translocation renal cell carcinoma. The Journal of Pathology. 268(1). 77–88.

Asrani, Kaushal, Adrianna A. Mendes, Juhyung Woo, et al.. (2025). SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesis. Nature Communications. 16(1). 8822–8822.

Alesi, Nicola, Kaushal Asrani, Tamara L. Lotan, & Elizabeth P. Henske. (2024). The Spectrum of Renal “TFEopathies”: Flipping the mTOR Switch in Renal Tumorigenesis. Physiology. 39(6). 347–359. 2 indexed citations

Williamson, Sean R., Shivani Kandukuri, Kristýna Pivovarčíková, et al.. (2024). Genetic validation of a TSC2 immunohistochemistry assay in TSC/mTOR-pathway altered renal tumors. Human Pathology. 154. 105693–105693. 3 indexed citations

Asrani, Kaushal, Juhyung Woo, Adrianna A. Mendes, et al.. (2022). An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nature Communications. 13(1). 6808–6808. 26 indexed citations

Salles, Daniela C., Kaushal Asrani, Juhyung Woo, et al.. (2022). GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms. The Journal of Pathology. 257(2). 158–171. 61 indexed citations

Asrani, Kaushal, Juhyung Woo, Thiago Vidotto, et al.. (2021). Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. The Journal of Pathology. 255(4). 425–437. 22 indexed citations

Kaur, Harsimar, Iryna Samarska, Jiayun Lu, et al.. (2020). Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance. The Prostate. 80(12). 1012–1023. 24 indexed citations

Phatak, Pornima, et al.. (2020). MicroRNA‐141‐3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1. Molecular Carcinogenesis. 60(2). 125–137. 19 indexed citations

10.

Asrani, Kaushal, Sanjana Murali, Brandon Lam, et al.. (2019). mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation. Journal of Clinical Investigation. 129(12). 5584–5599. 31 indexed citations

11.

Noë, Michaël, Neda Rezaee, Kaushal Asrani, et al.. (2018). Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. American Journal Of Pathology. 188(7). 1530–1535. 33 indexed citations

12.

Asrani, Kaushal, Anil K. Sood, Alba Torres, et al.. (2017). mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation. Journal of Clinical Investigation. 127(11). 4001–4017. 27 indexed citations

13.

Asrani, Kaushal, Ruth A. Keri, Rebeca Galisteo, et al.. (2013). The HER2- and Heregulin β1 (HRG)–Inducible TNFR Superfamily Member Fn14 Promotes HRG-Driven Breast Cancer Cell Migration, Invasion, and MMP9 Expression. Molecular Cancer Research. 11(4). 393–404. 36 indexed citations

14.

Whitsett, Timothy G., Emily H. Cheng, Landon J. Inge, et al.. (2012). Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion. American Journal Of Pathology. 181(1). 111–120. 45 indexed citations

15.

Zhou, Hong, Sühendan Ekmekçioglu, John W. Marks, et al.. (2012). The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment. Journal of Investigative Dermatology. 133(4). 1052–1062. 47 indexed citations

16.

Bennett, Jessica M., et al.. (2009). Abstract #4406: Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway. Cancer Research. 69. 4406–4406. 1 indexed citations

17.

Bennett, Jessica M., et al.. (2009). Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway. Journal of Biological Chemistry. 284(27). 17947–17955. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact